In fact, there have been reports of TGF-β supported tumour invasion by several mechanisms, for example, stimulating the trans-differentiation of epithelial cancer cells into migratory mesenchymal cells, namely the EMT process (Yu et al., 2014). The gene discussed is TGFB1; the disease is neoplasm.